Literature DB >> 11421849

Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia.

D Bathgate1, J S Snowden, A Varma, A Blackshaw, D Neary.   

Abstract

OBJECTIVES: The study aimed to increase understanding of behavioural changes in frontotemporal dementia (FTD) and identify features that best differentiate FTD from Alzheimer's disease (AD) and cerebrovascular dementia (CvD).
METHODS: A semi-structured questionnaire was administered to carers of 30 FTD, 75 AD and 34 CvD patients.
RESULTS: Behavioural changes that strongly discriminated FTD from AD and to a lesser extent CvD were loss of emotions and insight, selfishness, disinhibition, personal neglect, gluttony and sweet food preference, wandering, motor and verbal stereotypies, loss of pain, echolalia and mutism. Irritability, hyposexuality and hypersomnia did not discriminate. Emotional, eating and stereotyped behaviours correctly classified 95% of patients using regression analysis.
CONCLUSIONS: Behavioural characteristics accurately differentiate FTD from AD and CvD. The findings highlight the particular importance of affective change in FTD, and underline the role of the frontotemporal lobes in emotion.

Entities:  

Mesh:

Year:  2001        PMID: 11421849     DOI: 10.1034/j.1600-0404.2001.2000236.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  61 in total

1.  Characterization of apathy in persons with frontotemporal dementia and the impact on family caregivers.

Authors:  Jennifer Merrilees; Glenna A Dowling; Erin Hubbard; Judy Mastick; Robin Ketelle; Bruce L Miller
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jan-Mar       Impact factor: 2.703

2.  Mutual gaze in Alzheimer's disease, frontotemporal and semantic dementia couples.

Authors:  Virginia E Sturm; Megan E McCarthy; Ira Yun; Anita Madan; Joyce W Yuan; Sarah R Holley; Elizabeth A Ascher; Adam L Boxer; Bruce L Miller; Robert W Levenson
Journal:  Soc Cogn Affect Neurosci       Date:  2010-06-29       Impact factor: 3.436

Review 3.  Non-pharmacological Management of Behavioral Symptoms in Frontotemporal and Other Dementias.

Authors:  Cynthia Barton; Robin Ketelle; Jennifer Merrilees; Bruce Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

4.  Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer's disease.

Authors:  J C Thompson; C L Stopford; J S Snowden; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

5.  Trajectories of behavioral disturbance in dementia.

Authors:  Tiffany W Chow; Jonathan D Fridhandler; Malcolm A Binns; Albert Lee; Jennifer Merrilees; Howie J Rosen; Robin Ketelle; Bruce L Miller
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

6.  Neuropsychiatric symptom profile differs based on pathology in patients with clinically diagnosed behavioral variant frontotemporal dementia.

Authors:  Gabriel C Léger; Sarah J Banks
Journal:  Dement Geriatr Cogn Disord       Date:  2013-10-10       Impact factor: 2.959

Review 7.  Psychotic symptoms in frontotemporal dementia.

Authors:  Devin Hall; Elizabeth C Finger
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

8.  Apathy and Disinhibition Related to Neuropathology in Amnestic Versus Behavioral Dementias.

Authors:  Letizia G Borges; Alfred W Rademaker; Eileen H Bigio; M-Marsel Mesulam; Sandra Weintraub
Journal:  Am J Alzheimers Dis Other Demen       Date:  2019-06-06       Impact factor: 2.035

9.  MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes.

Authors:  Yu Zhang; Maria Carmela Tartaglia; Norbert Schuff; Gloria C Chiang; Christopher Ching; Howard J Rosen; Maria Luisa Gorno-Tempini; Bruce L Miller; Michael W Weiner
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 10.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.